Inskip et al 2001, USA5 | | 1994–1998 | | Case–control | | ⩾18 | | 5 | 1.9 (0.6 to 5.9) | | 5 years of cell phone use |
Muscat et al 2002, USA6 | | 1997–1999 | | Case–control | | ⩾18 | 11 | 1.7 (0.5 to 5.1) | | 3–6 years of cell phone use |
Lönn et al 2004, Sweden; Interphone8 | | 1999–2002 | | Case–control | | 20–69 | 14 | 1.8 (0.8 to 4.3) | | ⩾10 years since first “regular” cell phone use, result for either side of head |
12 | 3.9 (1.6 to 9.5) | | ⩾10 years since first “regular” cell phone use on same side of head as tumour |
Christensen et al 2004, Denmark; Interphone9 | | 2000–2002 | | Case–control | | 20–69 | 45 | 0.9 (0.5 to 1.6) | | Regular use |
2 | 0.2 (0.04 to 1.1) | | ⩾10 years since first “regular” cell phone use. Significantly larger tumours among cellular phone users 1.66 cm3 vs1.39 cm3, p = 0.03. |
Schoemaker et al 2005, Denmark, Finland, Sweden, Norway, Scotland, England;, Interphone11 | 1999–2004 | | Case–control | | 18–69 (variable) | | 360 | 0.9 (0.7 to 1.1) | | Regular use |
23 | 1.8 (1.1 to 3.1) | | ⩾10 lifetime years of cell phone use on same side of head as tumour |
31 | 1.3 (0.8 to 2.0) | | ⩾10 years since first cell phone use on same side of head as tumour |
12 | 0.9 (0.5 to 1.8) | | ⩾10 lifetime years of cell phone use on opposite side of head as tumour |
20 | 1.0 (0.6 to 1.7) | | ⩾10 years since first cell phone use on opposite side of head as tumour |
Hardell et al 2006a, Sweden15 | | 1997–2003 | | Case–control | | 20–80 | | 130 | 1.7 (1.2 to 2.3) | | >1-year latency of cell phone use |
20 | 2.9 (1.6 to 5.5) | | >10-year latency of cell phone use |
10 | 3.5 (1.5 to 7.8) | | >10-year latency of ipsilateral cell phone use |
4 | 1.0 (0.3 to 2.9) | | >10-year latency of cordless phone use |
3 | 3.1 (0.8 to 12) | | >10-year latency of ipsilateral cordless phone use |
Schüz et al 2006, Denmark17 | | 1982–2002 | | Cohort | | ⩾18 | | 32 | SIR = 0.7 (0.5 to 1.03) | | No data on latency or laterality of tumour and use of mobile phone |
Takebayashi et al 2006, Tokyo18 | | 2000–2004 | | Case–control | | 30–69 | | 51 | 0.7 (0.4 to 1.2) | | Regular use |
4 | 0.8 (0.2 to 2.7) | | Length of use >8 years |
20 | 0.9 (0.5 to 1.6) | | Ipsilateral use |